Search

Your search keyword '"Ciolli, Stefania"' showing total 211 results
Start Over Author "Ciolli, Stefania"
211 results on '"Ciolli, Stefania"'

1. Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?

Author

Tedeschi, Alessandra, Frustaci, Anna Maria, Mauro, Francesca Romana, Chiarenza, Annalisa, Coscia, Marta, Ciolli, Stefania, Reda, Gianluigi, Laurenti, Luca, Varettoni, Marzia, Murru, Roberta, Baratè, Claudia, Sportoletti, Paolo, Greco, Antonino, Borella, Chiara, Rossi, Valentina, Deodato, Marina, Biagi, Annalisa, Zamprogna, Giulia, Pelle, Angelo Curto, Lapietra, Gianfranco, Vitale, Candida, Morelli, Francesca, Cassin, Ramona, Fresa, Alberto, Cavalloni, Chiara, Postorino, Massimiliano, Ielo, Claudia, Cairoli, Roberto, Di Raimondo, Francesco, Montillo, Marco, and Del Poeta, Giovanni

Published
2021
Full Text
View/download PDF

2. Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab

Author

Gentile, Massimo, Shanafelt, Tait D., Reda, Gianluigi, Mauro, Francesca Romana, Zirlik, Katja, Ciolli, Stefania, Laurenti, Luca, Del Principe, Maria Ilaria, Rossi, Davide, Di Renzo, Nicola, Molica, Stefano, Angrilli, Francesco, Coscia, Marta, Chiarenza, Annalisa, Giordano, Annamaria, Cutrona, Giovanna, Chaffee, Kari G., Parikh, Sameer A., Uccello, Giuseppina, Innocenti, Idanna, Tripepi, Giovanni, D’Arrigo, Graziella, Vigna, Ernesto, Recchia, Anna Grazia, Herishanu, Yair, Shvidel, Lev, Tadmor, Tamar, Cortelezzi, Agostino, Del Poeta, Giovanni, Gaidano, Gianluca, Di Raimondo, Francesco, Neri, Antonino, Ferrarini, Manlio, Foà, Robin, Polliack, Aaron, and Morabito, Fortunato

Published
2018
Full Text
View/download PDF

3. Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments

Author

Laurenti, Luca, Innocenti, Idanna, Autore, Francesco, Vannata, Barbara, Efremov, Dimitar G., Ciolli, Stefania, Del Poeta, Giovanni, Mauro, Francesca Romana, Cortelezzi, Agostino, Borza, Paola Anticoli, Ghio, Francesco, Mondello, Patrizia, Murru, Roberta, Gozzetti, Alessandro, Cariccio, Maria Rosa Lanza, Piccirillo, Nicola, Boncompagni, Riccardo, Cantonetti, Maria, Principe, Maria Ilaria Del, Reda, Gianluigi, Bongarzoni, Velia, Cervetti, Giulia, Pitini, Vincenzo, Foà, Robin, Sica, Simona, and D’Arena, Giovanni

Published
2015
Full Text
View/download PDF

5. Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study

Author

Visentin, Andrea, Mauro, Francesca Romana, Cibien, Francesca, Vitale, Candida, Reda, Gianluigi, Fresa, Alberto, Ciolli, Stefania, Pietrasanta, Daniela, Marchetti, Monia, Murru, Roberta, Gentile, Massimo, Rigolin, Gian Matteo, Quaglia, Francesca Maria, Scarfò, Lydia, Sportoletti, Paolo, Pravato, Stefano, Piazza, Francesco, Coscia, Marta, Laurenti, Luca, Molica, Stefano, Foà, Robin, Cuneo, Antonio, Trentin, Livio, Laurenti, Luca (ORCID:0000-0002-8327-1396), Visentin, Andrea, Mauro, Francesca Romana, Cibien, Francesca, Vitale, Candida, Reda, Gianluigi, Fresa, Alberto, Ciolli, Stefania, Pietrasanta, Daniela, Marchetti, Monia, Murru, Roberta, Gentile, Massimo, Rigolin, Gian Matteo, Quaglia, Francesca Maria, Scarfò, Lydia, Sportoletti, Paolo, Pravato, Stefano, Piazza, Francesco, Coscia, Marta, Laurenti, Luca, Molica, Stefano, Foà, Robin, Cuneo, Antonio, Trentin, Livio, and Laurenti, Luca (ORCID:0000-0002-8327-1396)

Abstract

NA

Published
2022

6. Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model

Author

Molica, Stefano, Giannarelli, Diana, Visentin, Andrea, Reda, Gianluigi, Sportoletti, Paolo, Frustaci, Anna Maria, Chiarenza, Annalisa, Ciolli, Stefania, Vitale, Candida, Laurenti, Luca, De Paoli, Lorenzo, Murru, Roberta, Gentile, Massimo, Moia, Riccardo, Rigolin, Gian Matteo, Levato, Luciano, Giordano, Annamaria, Del Poeta, Giovanni, Stelitano, Caterina, Deodato, Marina, Ielo, Claudia, Noto, Alessandro, Guarente, Valerio, Coscia, Marta, Tedeschi, Alessandra, Gaidano, Gianluca, Cuneo, Antonio, Foa, Robin, Trentin, Livio, Mauro, Francesca Romana, Laurenti, Luca (ORCID:0000-0002-8327-1396), Foa', Robin, Molica, Stefano, Giannarelli, Diana, Visentin, Andrea, Reda, Gianluigi, Sportoletti, Paolo, Frustaci, Anna Maria, Chiarenza, Annalisa, Ciolli, Stefania, Vitale, Candida, Laurenti, Luca, De Paoli, Lorenzo, Murru, Roberta, Gentile, Massimo, Moia, Riccardo, Rigolin, Gian Matteo, Levato, Luciano, Giordano, Annamaria, Del Poeta, Giovanni, Stelitano, Caterina, Deodato, Marina, Ielo, Claudia, Noto, Alessandro, Guarente, Valerio, Coscia, Marta, Tedeschi, Alessandra, Gaidano, Gianluca, Cuneo, Antonio, Foa, Robin, Trentin, Livio, Mauro, Francesca Romana, Laurenti, Luca (ORCID:0000-0002-8327-1396), and Foa', Robin

Abstract

NA

Published
2022

7. Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model

Author

Molica, Stefano, primary, Giannarelli, Diana, additional, Visentin, Andrea, additional, Reda, Gianluigi, additional, Sportoletti, Paolo, additional, Frustaci, Anna Maria, additional, Chiarenza, Annalisa, additional, Ciolli, Stefania, additional, Vitale, Candida, additional, Laurenti, Luca, additional, De Paoli, Lorenzo, additional, Murru, Roberta, additional, Gentile, Massimo, additional, Moia, Riccardo, additional, Rigolin, Gian Matteo, additional, Levato, Luciano, additional, Giordano, Annamaria, additional, Del Poeta, Giovanni, additional, Stelitano, Caterina, additional, Deodato, Marina, additional, Ielo, Claudia, additional, Noto, Alessandro, additional, Guarente, Valerio, additional, Coscia, Marta, additional, Tedeschi, Alessandra, additional, Gaidano, Gianluca, additional, Cuneo, Antonio, additional, Foa', Robin, additional, Trentin, Livio, additional, and Mauro, Francesca Romana, additional

Published
2022
Full Text
View/download PDF

8. Continuous treatment with Ibrutinib in 100 untreated patients with TP 53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study

Author

Visentin, Andrea, primary, Mauro, Francesca Romana, additional, Cibien, Francesca, additional, Vitale, Candida, additional, Reda, Gianluigi, additional, Fresa, Alberto, additional, Ciolli, Stefania, additional, Pietrasanta, Daniela, additional, Marchetti, Monia, additional, Murru, Roberta, additional, Gentile, Massimo, additional, Rigolin, Gian Matteo, additional, Quaglia, Francesca Maria, additional, Scarfò, Lydia, additional, Sportoletti, Paolo, additional, Pravato, Stefano, additional, Piazza, Francesco, additional, Coscia, Marta, additional, Laurenti, Luca, additional, Molica, Stefano, additional, Foà, Robin, additional, Cuneo, Antonio, additional, and Trentin, Livio, additional

Published
2021
Full Text
View/download PDF

9. Biological Significance and Prognostic Value of Cytogenetics in 160 Patients with Multiple Myeloma: Predictivity of 13 and/or 14 Monosomies

Author

Vincelli, Jolanda Donatella, primary, Scopelliti, Antonio, additional, Violi, Angela, additional, Mammi', Corrado, additional, D'Errigo, Maria Grazia, additional, Bova, Irene, additional, Oliva, Bianca, additional, Garreffa, Cristina, additional, Martino, Massimo, additional, Ciolli, Stefania, additional, and Martino, Bruno, additional

Published
2021
Full Text
View/download PDF

10. Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Author

Mauro, Francesca Romana, primary, Giannarelli, Diana, additional, Visentin, Andrea, additional, Reda, Gianluigi, additional, Sportoletti, Paolo, additional, Frustaci, Anna Maria, additional, Chiarenza, Annalisa, additional, Ciolli, Stefania, additional, Vitale, Candida, additional, Laurenti, Luca, additional, De Paoli, Lorenzo, additional, Murru, Roberta, additional, Gentile, Massimo, additional, Rigolin, Gian Matteo, additional, Levato, Luciano, additional, Giordano, Annamaria, additional, Del Poeta, Giovanni, additional, Stelitano, Caterina, additional, Ielo, Claudia, additional, Noto, Alessandro, additional, Guarente, Valerio, additional, Molica, Stefano, additional, Coscia, Marta, additional, Tedeschi, Alessandra, additional, Gaidano, Gianluca, additional, Cuneo, Antonio, additional, Foà, Robin, additional, Martelli, Maurizio, additional, Girmenia, Corrado, additional, Gentile, Giuseppe, additional, and Trentin, Livio, additional

Published
2021
Full Text
View/download PDF

11. Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib?

Author

Tedeschi, Alessandra, Frustaci, Anna Maria, Mauro, Francesca Romana, Chiarenza, Annalisa, Coscia, Marta, Ciolli, Stefania, Reda, Gianluigi, Laurenti, Luca, Varettoni, Marzia, Murru, Roberta, Baratè, Claudia, Sportoletti, Paolo, Greco, Antonino, Borella, Chiara, Rossi, Valentina, Deodato, Marina, Biagi, Annalisa, Zamprogna, Giulia, Curto Pelle, Angelo, Lapietra, Gianfranco, Vitale, Candida, Morelli, Francesca, Cassin, Ramona, Fresa, Alberto, Cavalloni, Chiara, Postorino, Massimiliano, Ielo, Claudia, Cairoli, Roberto, Di Raimondo, Francesco, Montillo, Marco, and Del Poeta, Giovanni

Subjects
Settore MED/15 - MALATTIE DEL SANGUE, chronic lymphocytic leukaemia
Published
2021

13. An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

Author

Cortelezzi, Agostino, Gritti, Giuseppe, Laurenti, Luca, Cuneo, Antonio, Ciolli, Stefania, Di Renzo, Nicola, Musto, Pellegrino, Mauro, Francesca R., Cascavilla, Nicola, Falchi, Lorenzo, Zallio, Francesco, Callea, Vincenzo, Maura, Francesco, Martinelli, Sara, Piciocchi, Alfonso, Reda, Gianluigi, and Foà, Robin

Published
2012
Full Text
View/download PDF

14. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience

Author

Laurenti, Luca, Tarnani, Michela, Nichele, Ilaria, Ciolli, Stefania, Cortelezzi, Agostino, Forconi, Francesco, Rossi, Davide, Mauro, Francesca Romana, DʼArena, Giovanni, Del Poeta, Giovanni, Montanaro, Marco, Morabito, Fortunato, Musolino, Caterina, Callea, Vincenzo, Falchi, Lorenzo, Tedeschi, Alessandra, Ambrosetti, Achille, Gaidano, Gianluca, Leone, Giuseppe, and Foà, Robin

Published
2011
Full Text
View/download PDF

15. Retrospective Real-Life Comparison of Obinutuzumab Plus Chlorambucil Versus Ibrutinib in Previously Untreated and Unfit Patients with Chronic Lymphocytic Leukemia without TP53 Disruptions. Interim Results from the Italian CLL Campus

Author

Visentin, Andrea, primary, Mauro, Francesca Romana, additional, Pietrasanta, Daniela, additional, Fresa, Alberto, additional, Vitale, Candida, additional, Ciolli, Stefania, additional, Cassin, Ramona, additional, Cibien, Francesca, additional, Sportoletti, Paolo, additional, Gentile, Massimo, additional, Rigolin, Gian Matteo, additional, Quaglia, Francesca M., additional, Murru, Roberta, additional, Gozzetti, Alessandro, additional, Molica, Stefano, additional, Marchetti, Monia, additional, Scarfo, Lydia, additional, Reda, Gianluigi, additional, Coscia, Marta, additional, Laurenti, Luca, additional, Pizzolo, Giovanni, additional, Semenzato, Gianpietro, additional, Foà, Robin, additional, Cuneo, Antonio, additional, and Trentin, Livio, additional

Published
2020
Full Text
View/download PDF

16. Do Age, Fitness and Concomitant Medications Influence Management and Outcomes of CLL Patients Treated with Ibrutinib?

Author

Tedeschi, Alessandra, primary, Frustaci, Anna Maria, additional, Mauro, Francesca Romana, additional, Chiarenza, Annalisa, additional, Coscia, Marta, additional, Ciolli, Stefania, additional, Reda, Gianluigi, additional, Laurenti, Luca, additional, Varettoni, Marzia, additional, Murru, Roberta, additional, Baratè, Claudia, additional, Sportoletti, Paolo, additional, Greco, Antonino, additional, Borella, Chiara, additional, Rossi, Valentina, additional, Deodato, Marina, additional, Biagi, Annalisa, additional, Curto Pelle, Angelo, additional, Lapietra, Gianfranco, additional, Vitale, Candida, additional, Morelli, Francesca, additional, Cassin, Ramona, additional, Fresa, Alberto, additional, Flospergher, Elena, additional, Postorino, Massimiliano, additional, Di Prima, Alessio, additional, Cairoli, Roberto, additional, Di Raimondo, Francesco, additional, Montillo, Marco, additional, and Del Poeta, Giovanni, additional

Published
2020
Full Text
View/download PDF

17. Role of Age, Fitness and Concomitant Medications in CLL Patients Treated with Venetoclax

Author

Frustaci, Anna Maria, primary, Biagi, Annalisa, additional, Chiarenza, Annalisa, additional, Coscia, Marta, additional, Ciolli, Stefania, additional, Laurenti, Luca, additional, Sportoletti, Paolo, additional, Reda, Gianluigi, additional, Varettoni, Marzia, additional, Mauro, Francesca Romana, additional, Murru, Roberta, additional, Baratè, Claudia, additional, Greco, Antonino, additional, Borella, Chiara, additional, Zamprogna, Giulia, additional, Martino, Enrica Antonia, additional, Vitale, Candida, additional, Morelli, Francesca, additional, Fresa, Alberto, additional, Guarente, Valerio, additional, Noto, Alessandro, additional, Postorino, Massimiliano, additional, Cairoli, Roberto, additional, Montillo, Marco, additional, Del Poeta, Giovanni, additional, and Tedeschi, Alessandra, additional

Published
2020
Full Text
View/download PDF

18. A Patient with Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia and Multiple Myeloma

Author

Vincelli, Iolanda Donatella, primary, Cufari, Patrizia, additional, Toscano, Carmelo, additional, Said, Al Sayyad, additional, Campello, Mauro, additional, Caruso, Giuseppina, additional, D'Errigo, Maria Grazia, additional, Bova, Irene, additional, Mammi', Corrado, additional, Ciolli, Stefania, additional, Martino, Massimo, additional, Oliva, Bianca, additional, Garreffa, Cristina, additional, and Martino, Bruno, additional

Published
2020
Full Text
View/download PDF

21. Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA

Author

Morabito, Fortunato, Gentile, Massimo, Ciolli, Stefania, Petrucci, Maria T., Galimberti, Sara, Mele, Giuseppe, Casulli, Antonio F., Mannina, Donato, Piro, Eugenio, Pinotti, Graziella, Palmieri, Salvatore, Catalano, Lucio, Callea, Vincenzo, Offidani, Massimo, Musto, Pellegrino, Bringhen, Sara, Baldini, Luca, Tosi, Patrizia, Di Raimondo, Francesco, Boccadoro, Mario, Palumbo, Antonio, and Cavo, Michele

Published
2010
Full Text
View/download PDF

22. Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study

Author

Cuneo, Antonio, Follows, George, Rigolin, Gian Matteo, Piciocchi, Alfonso, Tedeschi, Alessandra, Trentin, Livio, Perez, Angeles Medina, Coscia, Marta, Laurenti, Luca, Musuraca, Gerardo, Farina, Lucia, Delgado, Alfredo Rivas, Orlandi, Ester Maria, Galieni, Piero, Mauro, Francesca Romana, Visco, Carlo, Amendola, Angela, Billio, Atto, Marasca, Roberto, Chiarenza, Annalisa, Meneghini, Vittorio, Ilariucci, Fiorella, Marchetti, Monia, Molica, Stefano, Re, Francesca, Gaidano, Gianluca, Gonzalez, Marcos, Forconi, Francesco, Ciolli, Stefania, Cortelezzi, Agostino, Montillo, Marco, Smolej, Lukas, Schuh, Anna, Eyre, Toby A, Kennedy, Ben, Bowles, Kris M, Vignetti, Marco, de la Serna, Javier, Moreno, Carol, Foà, Robin, Ghia, Paolo, GIMEMA, European Research Initiative on CLL (ERIC) and UK CLL forum, Cuneo, Antonio, Follows, George, Rigolin, Gian Matteo, Piciocchi, Alfonso, Tedeschi, Alessandra, Trentin, Livio, Perez, Angeles Medina, Coscia, Marta, Laurenti, Luca, Musuraca, Gerardo, Farina, Lucia, Delgado, Alfredo Riva, Orlandi, Ester Maria, Galieni, Piero, Mauro, Francesca Romana, Visco, Carlo, Amendola, Angela, Billio, Atto, Marasca, Roberto, Chiarenza, Annalisa, Meneghini, Vittorio, Ilariucci, Fiorella, Marchetti, Monia, Molica, Stefano, Re, Francesca, Gaidano, Gianluca, Gonzalez, Marco, Forconi, Francesco, Ciolli, Stefania, Cortelezzi, Agostino, Montillo, Marco, Smolej, Luka, Schuh, Anna, Eyre, Toby A., Kennedy, Ben, Bowles, Kris M., Vignetti, Marco, De La Serna, Javier, Moreno, Carol, Foà, Robin, and Ghia, Paolo

Subjects
Oncology, Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study, Salvage therapy, chemistry.chemical_compound, rituximab, 0302 clinical medicine, Piperidines, Antineoplastic Combined Chemotherapy Protocols, Bendamustine Hydrochloride, Aged, 80 and over, education.field_of_study, clinical trial, Hematology, Middle Aged, Prognosis, Fludarabine, Treatment Outcome, Italy, 030220 oncology & carcinogenesis, Ibrutinib, Bendamustine, Retreatment, Rituxima, Rituximab, medicine.drug, Chronic Lymphocytic Leukemia, bendamustine, ibrutinib, Adult, medicine.medical_specialty, Population, NO, 03 medical and health sciences, Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, Chemoimmunotherapy, CLL, Bendamustine, Rituxima, prognosis, Hematology, Internal medicine, medicine, Biomarkers, Tumor, Humans, Progression-free survival, education, Aged, Salvage Therapy, business.industry, Adenine, ERIC and UK CLL FORUM study, Leukemia, Lymphocytic, Chronic, B-Cell, Survival Analysis, United Kingdom, Regimen, Pyrimidines, chemistry, chronic lymphocytic leukemia, Pyrazoles, prognosis, business, CLL, 030215 immunology
Abstract

We performed an observational study on the efficacy of bendamustine and rituximab (BR) as first salvage regimen in chronic lymphocytic leukemia (CLL). In an intention-to-treat analysis including 237 patients, the median progression-free survival (PFS) was 25 months. The presence of del (17p), unmutated IGHV and advanced stage were associated with a shorter PFS at multivariate analysis. The median time-to-next treatment was 31.3 months. Front-line treatment with a chemoimmunotherapy regimen was the only predictive factor for a shorter time to next treatment at multivariate analysis. The median overall survival (OS) was 74.5 months. Advanced disease stage (i.e. Rai stage III-IV or Binet stage C) and resistant disease were the only parameters significantly associated with a shorter OS. Grade 3-5 infections were recorded in 6.3% of patients. A matched-adjusted indirect comparison with ibrutinib given second-line within Named Patient Programs in the United Kingdom and in Italy was carried out with OS as objective end point. When restricting the analysis to patients with intact 17p who had received chemoimmunotherapy in first line, there was no difference in OS between patients treated with ibrutinib (63% alive at 36 months) and patients treated with BR (74.4% alive at 36 months). BR is an efficacious first salvage regimen in CLL in a real-life population, including the elderly and unfit patients. BR and ibrutinib may be equally effective in terms of OS when used as first salvage treatment in patients without 17p deletion. (Registered at clinicaltrials.gov identifier: 02491398).

Published
2018

25. Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience

Author

Innocenti, Idanna, Morelli, Francesca, Autore, Francesco, Piciocchi, Alfonso, Frustaci, Annamaria, Mauro, Francesca R, Schiattone, Luana, Trentin, Livio, Del Poeta, Giovanni, Reda, Gianluigi, Rigolin, Gian M, Ibatici, Adalberto, Ciolli, Stefania, Coscia, Marta, Sportoletti, Paolo, Murru, Roberta, Levato, Luciano, Gentile, Massimo, D'Arena, Giovanni, Efremov, Dimitar G, Tedeschi, Alessandra, Scarfò, Lydia, Cuneo, Antonio, Foà, Robin, Laurenti, Luca, Laurenti, Luca (ORCID:0000-0002-8327-1396), Innocenti, Idanna, Morelli, Francesca, Autore, Francesco, Piciocchi, Alfonso, Frustaci, Annamaria, Mauro, Francesca R, Schiattone, Luana, Trentin, Livio, Del Poeta, Giovanni, Reda, Gianluigi, Rigolin, Gian M, Ibatici, Adalberto, Ciolli, Stefania, Coscia, Marta, Sportoletti, Paolo, Murru, Roberta, Levato, Luciano, Gentile, Massimo, D'Arena, Giovanni, Efremov, Dimitar G, Tedeschi, Alessandra, Scarfò, Lydia, Cuneo, Antonio, Foà, Robin, Laurenti, Luca, and Laurenti, Luca (ORCID:0000-0002-8327-1396)

Abstract

na

Published
2019

29. Venetoclax in CLL patients who progress after B‐cell Receptor inhibitor treatment: a retrospective multi‐centre Italian experience

Author

Innocenti, Idanna, primary, Morelli, Francesca, additional, Autore, Francesco, additional, Piciocchi, Alfonso, additional, Frustaci, Annamaria, additional, Mauro, Francesca R., additional, Schiattone, Luana, additional, Trentin, Livio, additional, Del Poeta, Giovanni, additional, Reda, Gianluigi, additional, Rigolin, Gian M., additional, Ibatici, Adalberto, additional, Ciolli, Stefania, additional, Coscia, Marta, additional, Sportoletti, Paolo, additional, Murru, Roberta, additional, Levato, Luciano, additional, Gentile, Massimo, additional, D'Arena, Giovanni, additional, Efremov, Dimitar G., additional, Tedeschi, Alessandra, additional, Scarfò, Lydia, additional, Cuneo, Antonio, additional, Foà, Robin, additional, and Laurenti, Luca, additional

Published
2019
Full Text
View/download PDF

30. Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian center

Author

Grandi, Vieri, primary, Maglie, Roberto, additional, Antiga, Emiliano, additional, Vannucchi, Margherita, additional, Delfino, Chiara, additional, Lastrucci, Irene, additional, Gunnella, Susanna, additional, Ciolli, Stefania, additional, Quintarelli, Lavinia, additional, Massi, Daniela, additional, Caproni, Marzia, additional, and Pimpinelli, Nicola, additional

Published
2019
Full Text
View/download PDF

33. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

Author

Annino, Luciana, Vegna, Maria Luce, Camera, Andrea, Specchia, Giorgina, Visani, Giuseppe, Fioritoni, Giuseppe, Ferrara, Felicetto, Peta, Antonio, Ciolli, Stefania, Deplano, Wilma, Fabbiano, Francesco, Sica, Simona, Di Raimondo, Francesco, Cascavilla, Nicola, Tabilio, Antonio, Leoni, Pietro, Invernizzi, Rosangela, Baccarani, Michele, Rotoli, Bruno, Amadori, Sergio, and Mandelli, Franco

Published
2002
Full Text
View/download PDF

34. CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia

Author

D'Arena, Giovanni, Vitale, Candida, Rossi, Giovanni, Coscia, Marta, Omedè, Paola, D'Auria, Fiorella, Statuto, Teodora, Valvano, Luciana, Ciolli, Stefania, Gilestro, Milena, Molica, Stefano, Bellesi, Silvia, Topini, Giuseppe, Panichi, Valentina, Autore, Francesco, Innocenti, Idanna, Musto, Pellegrino, Deaglio, Silvia, Laurenti, Luca, Del Vecchio, Luigi, Laurenti, Luca (ORCID:0000-0002-8327-1396), D'Arena, Giovanni, Vitale, Candida, Rossi, Giovanni, Coscia, Marta, Omedè, Paola, D'Auria, Fiorella, Statuto, Teodora, Valvano, Luciana, Ciolli, Stefania, Gilestro, Milena, Molica, Stefano, Bellesi, Silvia, Topini, Giuseppe, Panichi, Valentina, Autore, Francesco, Innocenti, Idanna, Musto, Pellegrino, Deaglio, Silvia, Laurenti, Luca, Del Vecchio, Luigi, and Laurenti, Luca (ORCID:0000-0002-8327-1396)

Abstract

N/A

Published
2018

35. Efficacy and Safety of Bendamustine and Rituximab As First Salvage Treatment in Chronic Lymphocytic Leukemia: Results of the Gimema-Eric LLC1315 Study

Author

Cuneo, Antonio, Gian Matteo Rigolin, Piciocchi, Alfonso, Moreno, Carol, Billio, Atto, Cortelezzi, Agostino, Galieni, Piero, Laurenti, Luca, Mauro, Francesca Romana, Molica, Stefano, Gentile, Massimo, Montillo, Marco, Trentin, Livio, Perez, Angeles Medina, Coscia, Marta, Musuraca, Gerardo, Farina, Lucia, Rivas-Delgado, Alfredo, Orlandi, Ester Maria, Ciolli, Stefania, Visco, Carlo, Pizzuti, Michele, Marasca, Roberto, Marchetti, Monia, Re, Francesca, Chiarenza, Gonzalez Annalisa, Meneghini, Vittorio, Ilariucci, Fiorella, Gaidano, Gianluca, Vignetti, Marco, La Serna, Javier, Foa, Robin, Follows, George A., and Ghia, Paolo

Subjects
Ibrutinib, CLL, Bendamustina, Ibrutinib, Bendamustina, CLL, NO
Published
2017

37. Predictive value of the CLL‐IPI in CLL patients receiving chemo‐immunotherapy as first‐line treatment

Author

Gentile, Massimo, primary, Shanafelt, Tait D., additional, Mauro, Francesca Romana, additional, Reda, Gianluigi, additional, Rossi, Davide, additional, Laurenti, Luca, additional, Del Principe, Maria Ilaria, additional, Cutrona, Giovanna, additional, Angeletti, Ilaria, additional, Coscia, Marta, additional, Herishanu, Yair, additional, Chiarenza, Annalisa, additional, Molica, Stefano, additional, Ciolli, Stefania, additional, Goldschmidt, Neta, additional, Angrilli, Francesco, additional, Giordano, Annamaria, additional, Rago, Angela, additional, Bairey, Osnat, additional, Tripepi, Giovanni, additional, Chaffee, Kari G., additional, Sameer, Parikh A., additional, Vigna, Ernesto, additional, Zirlik, Katja, additional, Shvidel, Lev, additional, Innocenti, Idanna, additional, Recchia, Anna Grazia, additional, Di Raimondo, Francesco, additional, Del Poeta, Giovanni, additional, Cortelezzi, Agostino, additional, Neri, Antonino, additional, Ferrarini, Manlio, additional, Gaidano, Gianluca, additional, Kay, Neil E., additional, Polliack, Aaron, additional, Foà, Robin, additional, and Morabito, Fortunato, additional

Published
2018
Full Text
View/download PDF

38. Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study

Author

Cuneo, Antonio, primary, Follows, George, additional, Rigolin, Gian Matteo, additional, Piciocchi, Alfonso, additional, Tedeschi, Alessandra, additional, Trentin, Livio, additional, Perez, Angeles Medina, additional, Coscia, Marta, additional, Laurenti, Luca, additional, Musuraca, Gerardo, additional, Farina, Lucia, additional, Delgado, Alfredo Rivas, additional, Orlandi, Ester Maria, additional, Galieni, Piero, additional, Mauro, Francesca Romana, additional, Visco, Carlo, additional, Amendola, Angela, additional, Billio, Atto, additional, Marasca, Roberto, additional, Chiarenza, Annalisa, additional, Meneghini, Vittorio, additional, Ilariucci, Fiorella, additional, Marchetti, Monia, additional, Molica, Stefano, additional, Re, Francesca, additional, Gaidano, Gianluca, additional, Gonzalez, Marcos, additional, Forconi, Francesco, additional, Ciolli, Stefania, additional, Cortelezzi, Agostino, additional, Montillo, Marco, additional, Smolej, Lukas, additional, Schuh, Anna, additional, Eyre, Toby A., additional, Kennedy, Ben, additional, Bowles, Kris M., additional, Vignetti, Marco, additional, de la Serna, Javier, additional, Moreno, Carol, additional, Foà, Robin, additional, and Ghia, Paolo, additional

Published
2018
Full Text
View/download PDF

39. CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia

Author

D'Arena, Giovanni, primary, Vitale, Candida, additional, Rossi, Giovanni, additional, Coscia, Marta, additional, Omedè, Paola, additional, D'Auria, Fiorella, additional, Statuto, Teodora, additional, Valvano, Luciana, additional, Ciolli, Stefania, additional, Gilestro, Milena, additional, Molica, Stefano, additional, Bellesi, Silvia, additional, Topini, Giuseppe, additional, Panichi, Valentina, additional, Autore, Francesco, additional, Innocenti, Idanna, additional, Musto, Pellegrino, additional, Deaglio, Silvia, additional, Laurenti, Luca, additional, and Del Vecchio, Luigi, additional

Published
2018
Full Text
View/download PDF

40. Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification.

Author

Laurenti, Luca, Innocenti, Idanna, Autore, Francesco, Ciolli, Stefania, Romana Mauro, Francesca, Mannina, Donato, Del Poeta, Giovanni, D'Arena, Giovanni, Massaia, Massimo, Coscia, Marta, Molica, Stefano, Pozzato, Gabriele, G Efremov, Dimitar, Vannata, Barbara, Marasca, Roberto, Galieni, Pietro, Cuneo, Antonio, Orlando, Sonia, Piciocchi, Alfonso, Boncompagni, Riccardo, Vincelli, Donatella, Marina Liberati, Anna, Russo, Filomena, Foá., Robin, Luca Laurenti (ORCID:0000-0002-8327-1396), Idanna Innocenti, Francesco Autore, Laurenti, Luca, Innocenti, Idanna, Autore, Francesco, Ciolli, Stefania, Romana Mauro, Francesca, Mannina, Donato, Del Poeta, Giovanni, D'Arena, Giovanni, Massaia, Massimo, Coscia, Marta, Molica, Stefano, Pozzato, Gabriele, G Efremov, Dimitar, Vannata, Barbara, Marasca, Roberto, Galieni, Pietro, Cuneo, Antonio, Orlando, Sonia, Piciocchi, Alfonso, Boncompagni, Riccardo, Vincelli, Donatella, Marina Liberati, Anna, Russo, Filomena, Foá., Robin, Luca Laurenti (ORCID:0000-0002-8327-1396), Idanna Innocenti, and Francesco Autore

Abstract

First-line treatment for young/fit patients with chronic lymphocytic leukemia (CLL) is the combination of flu- d arabine, cyclophosphamide and rituximab (FCR), which has improved these patients’ progression-free survival a nd overall survival, 1 b ut is poorly tolerated by elderly patients or patients with comorbidities. 2 Such patients have been historically treated with chlorambucil, which is well tolerated but does not improve survival. 3 To improve outcomes, chlorambucil has been combined with anti-CD20 monoclonal antibodies. Three prospec- tive studies 4-6 and one retrospective 7 one investigated the combination of chlorambucil with rituximab (Chl-R) as front-line treatment for elderly CLL patients or for younger patients unsuitable for fludarabine-based thera- pies. Overall response rates ranging from 66% to 84% have been reported, with complete response rates of 8- 26% and progression-free survival from 16.3 to 34.7 months

Published
2017

41. Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification

Author

Laurenti, Luca, primary, Innocenti, Idanna, additional, Autore, Francesco, additional, Ciolli, Stefania, additional, Mauro, Francesca Romana, additional, Mannina, Donato, additional, Del Poeta, Giovanni, additional, D’Arena, Giovanni, additional, Massaia, Massimo, additional, Coscia, Marta, additional, Molica, Stefano, additional, Pozzato, Gabriele, additional, Efremov, Dimitar G., additional, Vannata, Barbara, additional, Marasca, Roberto, additional, Galieni, Pietro, additional, Cuneo, Antonio, additional, Orlando, Sonia, additional, Piciocchi, Alfonso, additional, Boncompagni, Riccardo, additional, Vincelli, Donatella, additional, Liberati, Anna Marina, additional, Russo, Filomena, additional, and Foá, Robin, additional

Published
2017
Full Text
View/download PDF

42. Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification

Author

Laurenti, Luca, primary, Innocenti, Idanna, additional, Autore, Francesco, additional, Pasquale, Raffaella, additional, Vannata, Barbara, additional, Ciolli, Stefania, additional, Mauro, Francesca Romana, additional, Mannina, Donato, additional, Del Poeta, Giovanni, additional, D'Arena, Giovanni, additional, Massaia, Massimo, additional, Coscia, Marta, additional, Molica, Stefano, additional, Pozzato, Gabriele, additional, Efremov, Dimitar G, additional, Marasca, Roberto, additional, Galieni, Piero, additional, Cuneo, Antonio, additional, Orlando, Sonia, additional, Piciocchi, Alfonso, additional, Boncompagni, Riccardo, additional, Vincelli, Donatella Iolanda, additional, Liberati, Anna Marina, additional, Russo, Filomena, additional, and Foa, Robin, additional

Published
2016
Full Text
View/download PDF

44. Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials

Author

Gentile, Massimo, primary, Zirlik, Katja, additional, Ciolli, Stefania, additional, Mauro, Francesca R., additional, Di Renzo, Nicola, additional, Mastrullo, Lucia, additional, Angrilli, Francesco, additional, Molica, Stefano, additional, Tripepi, Giovanni, additional, Giordano, Annamaria, additional, Di Raimondo, Francesco, additional, Selleri, Carmine, additional, Coscia, Marta, additional, Musso, Maurizio, additional, Orsucci, Lorella, additional, Mannina, Donato, additional, Rago, Angela, additional, Giannotta, Angela, additional, Ferrara, Felicetto, additional, Herishanu, Yair, additional, Shvidel, Lev, additional, Tadmor, Tamar, additional, Scortechini, Ilaria, additional, Ilariucci, Fiorella, additional, Murru, Roberta, additional, Guarini, Attilio, additional, Musuraca, Gerardo, additional, Mineo, Giuseppe, additional, Vincelli, Iolanda, additional, Arcari, Annalisa, additional, Tarantini, Giuseppe, additional, Caparrotti, Giuseppe, additional, Chiarenza, Annalisa, additional, Levato, Luciano, additional, Villa, Maria Rosaria, additional, De Paolis, Maria Rosaria, additional, Zinzani, Pier Luigi, additional, Polliack, Aaron, additional, and Morabito, Fortunato, additional

Published
2016
Full Text
View/download PDF

45. A Patient with Chronic Lymphocytic Leukemia and Bone Localization: A Case Report

Author

Vincelli, Iolanda Donatella, primary, Cufari, Patrizia, additional, al Sayyad, Said, additional, Tuscano, Carmelo, additional, Porta, Natale, additional, di Cristofano, Claudio, additional, Petrozza, Vincenzo, additional, Aricò, Demetrio, additional, Stelitano, Caterina, additional, Ciolli, Stefania, additional, Iaria, Grazia, additional, Violi, Angela, additional, and Ronco, Francesca, additional

Published
2015
Full Text
View/download PDF

46. Fast and Non-Invasive Identification of Tumorigenic-Proliferative Biomarker in Myeloproliferative and Lymphoproliferative Disorders

Author

Vincelli, Iolanda Donatella, primary, Martino, Bruno, additional, Cuzzola, Maria, additional, Irrera, Giuseppe, additional, Cufari, Patrizia, additional, Martino, Massimo, additional, Gentile, Massimo, additional, Ciolli, Stefania, additional, Zaccuri, AnnaMaria, additional, Pontoriero, Daniela, additional, Rigolino, Carmela, additional, Violi, Angela, additional, and Ronco, Francesca, additional

Published
2015
Full Text
View/download PDF

47. Bendamustine with Rituximab Is Safe and Effective As FRONT LINE Therapy in Elderly B-CLL Patients. an ITALIAN RETROSPECTIVE MULTICENTER Experience

Author

Laurenti, Luca, primary, Autore, Francesco, additional, Innocenti, Idanna, additional, Vannata, Barbara, additional, Cantonetti, Maria, additional, Del Principe, Maria Ilaria, additional, Mauro, Francesca Romana, additional, Paola, Anticoli Borza, additional, Bongarzoni, Velia, additional, Ciolli, Stefania, additional, Boncompagni, Riccardo, additional, Sciumé, Mariarita, additional, Vincenti, Daniele, additional, Ghio, Francesco, additional, Cecconi, Nadia, additional, Pitini, Vincenzo, additional, Mondello, Patrizia, additional, Lanza Cariccio, Maria Rosa, additional, Gozzetti, Alessandro, additional, D'Arena, Giovanni, additional, Murru, Roberta, additional, Piccirillo, Nicola, additional, Petrini, Mario, additional, Cortelezzi, Agostino, additional, Del Poeta, Giovanni, additional, Foà, Robin, additional, and Sica, Simona, additional

Published
2014
Full Text
View/download PDF

48. Bendamustine in Combination with Rituximab for Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients: An Italian Retrospective Multicentre Study

Author

Gentile, Massimo, primary, Ciolli, Stefania, additional, Molica, Stefano, additional, Di Renzo, Nicola, additional, Selleri, Carmine, additional, Villa, Maria Rosaria, additional, De Paolis, Maria Rosaria, additional, Scortechini, Ilaria, additional, Giannotta, Angela, additional, Minoia, Carla, additional, Rago, Angela, additional, Boncompagni, Riccardo, additional, Bonanno, Vincenza, additional, Levato, Luciano, additional, Musso, Maurizio, additional, Mastrullo, Lucia, additional, Melpignano, Angela, additional, Murru, Roberta, additional, Angelucci, Emanuele, additional, Tarantini, Giuseppe, additional, Caparrotti, Giuseppe, additional, Guarini, Attilio, additional, Ferrara, Felicetto, additional, Cimino, Giuseppe, additional, Zinzani, Pier Luigi, additional, and Morabito, Fortunato, additional

Published
2014
Full Text
View/download PDF

49. Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients

Author

Foà, Robin, primary, Del Giudice, Ilaria, additional, Cuneo, Antonio, additional, Del Poeta, Giovanni, additional, Ciolli, Stefania, additional, Di Raimondo, Francesco, additional, Lauria, Francesco, additional, Cencini, Emanuele, additional, Rigolin, Gian Matteo, additional, Cortelezzi, Agostino, additional, Nobile, Francesco, additional, Callea, Vincenzo, additional, Brugiatelli, Maura, additional, Massaia, Massimo, additional, Molica, Stefano, additional, Trentin, Livio, additional, Rizzi, Rita, additional, Specchia, Giorgina, additional, Di Serio, Francesca, additional, Orsucci, Lorella, additional, Ambrosetti, Achille, additional, Montillo, Marco, additional, Zinzani, Pier Luigi, additional, Ferrara, Felicetto, additional, Morabito, Fortunato, additional, Mura, Maria Angela, additional, Soriani, Silvia, additional, Peragine, Nadia, additional, Tavolaro, Simona, additional, Bonina, Silvia, additional, Marinelli, Marilisa, additional, De Propris, Maria Stefania, additional, Starza, Irene Della, additional, Piciocchi, Alfonso, additional, Alietti, Alessandra, additional, Runggaldier, Eva Josephine, additional, Gamba, Enrica, additional, Mauro, Francesca Romana, additional, Chiaretti, Sabina, additional, and Guarini, Anna, additional

Published
2014
Full Text
View/download PDF

50. Rituximab Plus Chlorambucil As Initial Treatment for Elderly Patients with Chronic Lymphocytic Leukemia (CLL): Effect of Pre-Treatment Biological Characteristics and Gene Expression Patterns on Response to Treatment

Author

Foa, Robin, primary, Ciolli, Stefania, additional, Di Raimondo, Francesco, additional, Del Poeta, Giovanni, additional, Lauria, Francesco, additional, Forconi, Francesco, additional, Cuneo, Antonio, additional, Cortelezzi, Agostino, additional, Nobile, Francesco, additional, Callea, Vincenzo, additional, Brugiatelli, Maura, additional, Massaia, Massimo, additional, Molica, Stefano, additional, Trentin, Livio, additional, Rizzi, Rita, additional, Specchia, Giorgina, additional, Orsucci, Lorella, additional, Ambrosetti, Achille, additional, Montillo, Marco, additional, Zinzani, Pier Luigi, additional, Ferrara, Felicetto, additional, Morabito, Fortunato, additional, Mura, Maria Angela, additional, Soriani, Silvia, additional, Marinelli, Marilisa, additional, De Propris, Maria Stefania, additional, Alietti, Alessandra, additional, Runggaldier, Eva J., additional, Gamba, Enrica, additional, Del Giudice, Ilaria, additional, Bonina, Silvia, additional, Mauro, Francesca Romana, additional, Chiaretti, Sabina, additional, and Guarini, Anna, additional

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results